US equities
|
NVDA
$162.85
▼-2.01%
AMD
$534.06
▼-8.75%
MU
$778.31
▼-2.52%
AAPL
$356.27
▲+0.39%
MSFT
$523.88
▲+0.17%
TSLA
$390.22
▼-1.82%
AVGO
$347.01
▼-4.76%
SNDK
$885.01
▼-5.59%
NVDA
$162.85
▼-2.01%
AMD
$534.06
▼-8.75%
MU
$778.31
▼-2.52%
AAPL
$356.27
▲+0.39%
MSFT
$523.88
▲+0.17%
TSLA
$390.22
▼-1.82%
AVGO
$347.01
▼-4.76%
SNDK
$885.01
▼-5.59%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about NASDAQ:APLS
Recent news which mentions NASDAQ:APLS
APLS Stock Earnings: Apellis Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024
May 07, 2024
Tickers
APLS
Tags
APLS
Earnings Reports
Market News
From
InvestorPlace
Apellis Pharmaceuticals stock has lost 40% in 2024: buy the dip?
April 30, 2024
Tickers
APLS
USA
Tags
USA
Trading Ideas
North America
From
Invezz
Better Pharmaceutical Stock: Apellis or Novartis?
September 14, 2021
Tags
NYSE:NVS
NASDAQ:APLS
From
StockNews.com
APLS Stock: The Trial Results That Have Apellis Pharmaceuticals Plunging Today
September 10, 2021
Tickers
APLS
Tags
Today's Market
NASDAQ:APLS
APLS
From
InvestorPlace